Published in J Exp Med on August 01, 1981
Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation. J Exp Med (1983) 1.73
A monoclonal antibody to a human neutrophil-specific plasma membrane antigen. Effect of the antibody on the C3bi-mediated adherence by neutrophils and expression of the antigen during myelopoiesis. J Exp Med (1988) 0.88
Clonal growth of mammalian cells in vitro; growth characteristics of colonies from single HeLa cells with and without a feeder layer. J Exp Med (1956) 22.68
One-step growth curve of Western equine encephalomyelitis virus on chicken embryo cells grown in vitro and analysis of virus yields from single cells. J Exp Med (1954) 17.92
Plasminogen: purification from human plasma by affinity chromatography. Science (1970) 11.72
The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell (1978) 6.82
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses. J Exp Med (1973) 5.53
Studies on the nucleic acid sequences of Kirsten sarcoma virus: a model for formation of a mammalian RNA-containing sarcoma virus. J Virol (1973) 5.28
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses. J Exp Med (1973) 4.99
A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med (1978) 3.92
Fibrinolysis associated with oncogenic transformation. Requirement of plasminogen for correlated changes in cellular morphology, colony formation in agar, and cell migration. J Exp Med (1973) 3.16
Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides. Cell (1976) 3.13
Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm. Cell (1976) 2.87
ISOLATION AND IDENTIFICATION OF THE LONG-ACTING THYROID STIMULATOR AND ITS RELATION TO HYPERTHYROIDISM AND CIRCUMSCRIBED PRETIBIAL MYXEDEMA. J Clin Endocrinol Metab (1964) 2.78
Transplantable human neoplasms maintained in cortisone-treated laboratory animals: H.S. No. 1; H.Ep. No. 1; H.Ep. No. 2; H.Ep. No. 3; and H.Emb.Rh. No. 1. Cancer Res (1954) 2.73
Tumour promotor induces plasminogen activator. Nature (1976) 2.60
Studies on the role of plasminogen activator in ovulation. In vitro response of granulosa cells to gonadotropins, cyclic nucleotides, and prostaglandins. J Biol Chem (1976) 2.56
The origin and characteristics of a pig kidney cell strain, LLC-PK. In Vitro (1976) 2.44
Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue. Cell (1979) 2.13
Ovarian plasminogen activator: relationship to ovulation and hormonal regulation. Cell (1975) 1.93
Epidermal growth factor, like phorbol esters, induces plasminogen activator in HeLa cells. Nature (1978) 1.70
Phorbol ester-induced morphological changes in transformed chick fibroblasts: evidence for direct catalytic involvement of plasminogen activator. Cell (1979) 1.69
Studies on the function of cell surface glycoproteins. I. Use of antisera to surface membranes in the identification of membrane components relevant to cell-substrate adhesion. J Cell Biol (1979) 1.67
Fibrinolysis associated with oncogenic transformation. Morphological correlates. J Biol Chem (1974) 1.50
Anti-epidermal-cell-surface pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase. Proc Natl Acad Sci U S A (1978) 1.47
Plasminogen activator in chick fibroblasts: induction of synthesis by retinoic acid; synergism with viral transformation and phorbol ester. Cell (1978) 1.14
Production of plasminogen activator by established cell lines of mouse origin. J Cell Biol (1977) 1.11
Plasminogen activator in chick embryo muscle cells: induction of enzyme by RSV, PMA and retinoic acid. Cell (1978) 1.10
Loss of malignancy during serial passage of human carcinoma in culture and discordance between malignancy and transformation parameters. Cancer Res (1980) 1.02
Secretion of plasminogen activator by Sertoli cell enriched cultures. Mol Cell Endocrinol (1977) 1.01
Immunological enhancement by mouse isoantibodies: the importance of complement fixation. Immunology (1968) 0.93
Plasminogen activator synthesis by cultured human embryonic lung cells: characterization of the suppressive effect of corticosteroids. J Cell Physiol (1978) 0.84
The thyroid-stimulating properties of long-acting thyroid stimulator gamma G-globulin subunits. Biochim Biophys Acta (1969) 0.83
Antibody stimulation of tumour growth in T-cell depleted mice. Nature (1975) 0.81
Plasminogen activator synthesis accompanying chemical carcinogen-induced in vitro transformation of Syrian hamster and guinea-pig fetal cells. Int J Cancer (1980) 0.80
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A (1993) 10.82
Secretion of plasminogen activator by stimulated macrophages. J Exp Med (1974) 8.82
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses. J Exp Med (1973) 5.53
Actinomycin and nucleic acid function. Prog Nucleic Acid Res Mol Biol (1964) 5.00
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses. J Exp Med (1973) 4.99
A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med (1978) 3.92
Base specificity in the interaction of polynucleotides with antibiotic drugs. Science (1965) 3.72
Fluorescence studies of nucleotides and polynucleotides. I. Formycin, 2-aminopurine riboside, 2,6-diaminopurine riboside, and their derivatives. J Biol Chem (1969) 3.39
The human tissue plasminogen activator gene. J Biol Chem (1986) 3.35
Fibrinolysis associated with oncogenic transformation. Requirement of plasminogen for correlated changes in cellular morphology, colony formation in agar, and cell migration. J Exp Med (1973) 3.16
Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides. Cell (1976) 3.13
Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med (1987) 2.99
Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J Cell Biol (1999) 2.93
Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator. J Biol Chem (1974) 2.89
Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm. Cell (1976) 2.87
Antibodies to plasminogen activator inhibit human tumor metastasis. Cell (1983) 2.82
Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell (1998) 2.75
Replication and inheritance of mitochondrial DNA. Proc Natl Acad Sci U S A (1966) 2.72
Limits of body mass index to detect obesity and predict body composition. Nutrition (2001) 2.69
Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors. J Exp Med (1977) 2.60
Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate. Cell (1977) 2.47
Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res (2001) 2.45
Mortality trends in type 1 diabetes. The Allegheny County (Pennsylvania) Registry 1965-1999. Diabetes Care (2001) 2.36
Structural analysis of the waxy locus from Hordeum vulgare. Nucleic Acids Res (1988) 2.33
Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol Biol Cell (2001) 2.21
Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator. Eur J Biochem (1985) 2.14
Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue. Cell (1979) 2.13
Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes (2000) 2.07
Cloning and electrophysiological analysis of KST1, an inward rectifying K+ channel expressed in potato guard cells. EMBO J (1995) 2.05
Macrophage plasminogen activator: induction by products of activated lymphoid cells. J Exp Med (1977) 2.00
A proenzyme form of human urokinase. J Biol Chem (1982) 1.98
When should a substance be designated as sensitizing for the skin ('Sh') or for the airways ('Sa')? Hum Exp Toxicol (2002) 1.95
Ovarian plasminogen activator: relationship to ovulation and hormonal regulation. Cell (1975) 1.93
Properties of plasminogen activators formed by neoplastic human cell cultures. J Exp Med (1974) 1.88
Auxin-induced K+ channel expression represents an essential step in coleoptile growth and gravitropism. Proc Natl Acad Sci U S A (1999) 1.85
GORK, a delayed outward rectifier expressed in guard cells of Arabidopsis thaliana, is a K(+)-selective, K(+)-sensing ion channel. FEBS Lett (2000) 1.83
Radiation-induced DNA damage as a function of hydration. I. Release of unaltered bases. Radiat Res (1992) 1.80
Distinguishable transformation-defective phenotypes among temperature-sensitive mutants of Rous sarcoma virus. J Virol (1977) 1.79
Isolation and characterization of Clostridium botulinum type B toxin. J Biol Chem (1969) 1.79
Hormonal regulation of plasminogen activator mRNA production in porcine kidney cells. Cell (1983) 1.76
The acetylcholine receptor. I. Purification and characterization of a macromolecule isolated from Electrophorus electricus. J Biol Chem (1973) 1.75
Structure and activity of acetylcholine. Nature (1970) 1.75
Plasmid-determined fusidic acid resistance in the Enterobacteriaceae. J Gen Microbiol (1974) 1.74
Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat Med (1997) 1.72
Reevaluation of serum-plasma differences in total cholesterol concentration. JAMA (1990) 1.72
Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned? J Clin Endocrinol Metab (1997) 1.68
Late reactions to the patch-test preparations para-phenylenediamine and epoxy resin: a prospective multicentre investigation of the German Contact Dermatitis Research Group. Br J Dermatol (2006) 1.67
The interaction of actinomycin with DNA: requirement for the 2-amino group of purines. Proc Natl Acad Sci U S A (1967) 1.65
Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J Cell Biol (1994) 1.65
Prospective study of manikin-only versus manikin and human subject endotracheal intubation training of paramedics. Ann Emerg Med (1991) 1.63
Clinical performance of a laser fluorescence device for detection of occlusal caries lesions. Eur J Oral Sci (2001) 1.62
Performance and reproducibility of a laser fluorescence system for detection of occlusal caries in vitro. Caries Res (1999) 1.62
Intraoperative digital subtraction angiography and the surgical treatment of intracranial aneurysms and vascular malformations. J Neurosurg (1990) 1.60
Macrophage plasminogen activator: induction by asbestos is blocked by anti-inflammatory steroids. J Exp Med (1976) 1.60
Specific protease deficiency in polymorphonuclear leukocytes of Chédiak-Higashi syndrome and beige mice. J Exp Med (1978) 1.60
Purification of murine T cell growth factor. A lymphocyte mitogen with helper activity. J Exp Med (1981) 1.57
A specific labeling procedure for proteins on the outer surface of membranes. J Biol Chem (1972) 1.55
The identity of plant glutamate receptors. Science (2001) 1.53
K(+) channel profile and electrical properties of Arabidopsis root hairs. FEBS Lett (2001) 1.53
The Arabidopsis thaliana ABC transporter AtMRP5 controls root development and stomata movement. EMBO J (2001) 1.53
Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study. Neurology (2004) 1.52
Fibrinolysis associated with oncogenic transformation. Morphological correlates. J Biol Chem (1974) 1.50
Phospholipid composition of Rous sarcoma virus, host cell membranes and other enveloped RNA viruses. Virology (1971) 1.49
Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall Med (2008) 1.48
Isolation and characterization of urokinase from human plasma. J Biol Chem (1982) 1.47
Ammonium ions as the source of nitrogen for tryptophan biosynthesis in whole cells of Escherichia coli. Biochim Biophys Acta (1967) 1.46
Induction of hapten-specific tolerance by interleukin 10 in vivo. J Exp Med (1994) 1.46
cDNA and gene nucleotide sequence of porcine plasminogen activator. Nucleic Acids Res (1984) 1.43
Plasminogen, the serum proenzyme activated by factors from cells transformed by oncogenic viruses. J Biol Chem (1974) 1.43
Inward rectifier potassium channels in plants differ from their animal counterparts in response to voltage and channel modulators. Eur Biophys J (1995) 1.42
Antisense transcription: a critical look in both directions. Cell Mol Life Sci (2009) 1.42
Gene expression and cAMP. Proc Natl Acad Sci U S A (1985) 1.41
Molecular basis of plant-specific acid activation of K+ uptake channels. Proc Natl Acad Sci U S A (1997) 1.40
The importance of context information in the diagnostic rating of digital images of patch test reactions. Br J Dermatol (2009) 1.40
Radiation-induced DNA damage as a function of hydration. II. Base damage from electron-loss centers. Radiat Res (1996) 1.40
Peptide-derived antagonists of the urokinase receptor. affinity maturation by combinatorial chemistry, identification of functional epitopes, and inhibitory effect on cancer cell intravasation. Biochemistry (2001) 1.40
[Assessment of the capability of performance of patients with psychic and psychosomatic diseases--a diagnostic model]. Versicherungsmedizin (2011) 1.39
An improved assay for interleukin 2 (lymphocyte growth factor) produced by mitogen-activated lymphocytes. Aust J Exp Biol Med Sci (1980) 1.38
Acro-renal-ocular syndrome: expansion of the phenotype. Clin Dysmorphol (1998) 1.38
Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation. Br J Haematol (1994) 1.38
Calendar life span versus budding life span of Saccharomyces cerevisiae. Mech Ageing Dev (1980) 1.36
The inhibition of red cell and brain ATPase by delta-aminolaevulinic acid. Biochim Biophys Acta (1971) 1.36
Yields of OH in gamma-irradiated DNA as a function of DNA hydration: hole transfer in competition with OH formation. Radiat Res (1996) 1.35
Spatial distribution of vital and dead microorganisms in dental biofilms. Arch Oral Biol (2001) 1.34
Experimental model for quantitative study of metastasis. Cancer Res (1980) 1.32
Exonuclease VI, a new nuclease activity associated with E. coli DNA polymerase. Proc Natl Acad Sci U S A (1968) 1.32
Changes in malignant phenotype of a human carcinoma conditioned by growth environment. Cell (1983) 1.31
RNA and protein synthesis in human peripheral blood polymorphonuclear leukocytes. J Exp Med (1979) 1.30
High prevalence of congenital toxoplasmosis in Brazil estimated in a 3-year prospective neonatal screening study. Int J Epidemiol (2000) 1.30
Selective lysis of cells transformed by Rous Sarcoma virus. Virology (1971) 1.29